Varex Imaging (NASDAQ:VREX) Issues Q2 2026 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its second quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.150-0.250 for the period, compared to the consensus earnings per share estimate of 0.190. The company issued revenue guidance of $210.0 million-$215.0 million, compared to the consensus revenue estimate of $214.4 million.

Varex Imaging Price Performance

NASDAQ:VREX traded down $0.51 during midday trading on Wednesday, hitting $13.64. The company had a trading volume of 658,830 shares, compared to its average volume of 346,899. The company has a quick ratio of 1.83, a current ratio of 3.43 and a debt-to-equity ratio of 0.75. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $14.56. The stock’s fifty day moving average price is $12.84 and its 200-day moving average price is $11.74. The company has a market capitalization of $571.79 million, a PE ratio of -8.02 and a beta of 0.90.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.The company had revenue of $209.60 million during the quarter, compared to analysts’ expectations of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, research analysts expect that Varex Imaging will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on VREX. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 22nd. Oppenheimer dropped their price objective on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. B. Riley Financial reissued a “buy” rating and issued a $16.00 price objective on shares of Varex Imaging in a research note on Wednesday, November 19th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $14.50 price objective on shares of Varex Imaging in a research note on Monday, February 2nd. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $16.17.

Trending Headlines about Varex Imaging

Here are the key news stories impacting Varex Imaging this week:

• Positive Sentiment: Q1 beat consensus — Varex reported GAAP net income of $0.05 and non‑GAAP EPS of $0.19, topping the consensus $0.14; revenue was $209.6M, slightly above expectations. This shows underlying operational improvement and supports near‑term earnings momentum. Varex Announces Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Industrial end-market strength noted — Management highlighted strong industrial segment growth on the call and in the slide deck, which diversifies revenue drivers beyond healthcare imaging. That can support higher-margin opportunities over time. Varex Imaging Corp (VREX) Q1 2026 Earnings Call Highlights: Strong Industrial Growth and …
• Neutral Sentiment: Investor resources available — The company published its earnings slide deck and executives held an earnings call; the full transcript and presentation provide more color on product demand, supply chain and margin drivers for those modelling FY2026. Varex Imaging Corporation 2026 Q1 – Results – Earnings Call Presentation
• Neutral Sentiment: Earnings call transcript — For detail on management commentary (demand trends, backlog, cost actions) see the full call transcript; useful for refining models but not an immediate directional catalyst by itself. Varex Imaging Corporation (VREX) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Cautious Q2 guidance — Varex set Q2 FY2026 EPS guidance of $0.15–$0.25 (consensus ~$0.19) and revenue guidance $210–$215M (consensus ~$214.4M). The midpoint implies limited upside to Street estimates and the lower end is below consensus, which likely weighed on the stock. Varex Announces Financial Results for First Quarter Fiscal Year 2026
• Negative Sentiment: Cash flow and margin concerns — The quarter showed a $16M cash outflow from operations and mixed margin metrics (GAAP gross margin ~33%, non‑GAAP 34%, while some summaries note negative net‑margin on an LTM basis). These items increase near‑term execution risk and may pressure valuation until cash conversion stabilizes. Varex Announces Financial Results for First Quarter Fiscal Year 2026
• Negative Sentiment: Mixed fundamental takeaways from analysts — Coverage notes the beat but highlights that key metrics vs. estimates are mixed year‑over‑year, tempering conviction until follow‑through quarters confirm the recovery. VAREX IMAGING (VREX) Reports Q1 Earnings: What Key Metrics Have to Say

Institutional Trading of Varex Imaging

A number of large investors have recently bought and sold shares of VREX. The Manufacturers Life Insurance Company lifted its position in shares of Varex Imaging by 10.4% during the second quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after purchasing an additional 1,442 shares in the last quarter. Comerica Bank increased its holdings in Varex Imaging by 9.3% during the 3rd quarter. Comerica Bank now owns 20,363 shares of the company’s stock valued at $253,000 after purchasing an additional 1,726 shares during the period. BNP Paribas Financial Markets raised its holdings in Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after purchasing an additional 2,036 shares in the last quarter. Nebula Research & Development LLC increased its position in shares of Varex Imaging by 11.0% during the 2nd quarter. Nebula Research & Development LLC now owns 22,795 shares of the company’s stock valued at $198,000 after purchasing an additional 2,250 shares during the last quarter. Finally, Rhumbline Advisers increased its holdings in shares of Varex Imaging by 4.6% in the second quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock worth $536,000 after purchasing an additional 2,694 shares during the last quarter.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.